MENU
+Compare
OPORF
Stock ticker: OTC
AS OF
Jan 6 closing price
Price
$0.28
Change
-$0.09 (-24.32%)
Capitalization
150.67M

OPORF OPEN ORPHAN PLC. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
OPORF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for OPORF with price predictions
Jan 08, 2025

OPORF's RSI Indicator sits in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.010) is normal, around the industry mean (14.744). P/E Ratio (8.958) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). Dividend Yield (0.009) settles around the average of (0.013) among similar stocks. P/S Ratio (2.431) is also within normal values, averaging (264.079).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. OPORF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OPORF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
OPORF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
42, New Road
Phone
N/A
Employees
210
Web
https://www.hvivo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EHTH10.050.16
+1.62%
eHealth
SNA348.502.90
+0.84%
Snap-on
BTE2.64N/A
N/A
Baytex Energy Corp
LASE5.52-0.01
-0.18%
Laser Photonics Corp
HGTY9.66-0.10
-1.02%
Hagerty

OPORF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OPORF has been loosely correlated with YMAB. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if OPORF jumps, then YMAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OPORF
1D Price
Change %
OPORF100%
N/A
YMAB - OPORF
34%
Loosely correlated
-0.32%
ENTX - OPORF
31%
Poorly correlated
+4.93%
PMN - OPORF
23%
Poorly correlated
-2.19%
EWTX - OPORF
6%
Poorly correlated
-1.72%
BCTX - OPORF
4%
Poorly correlated
-1.82%
More